Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs

Mohamed A. Elrayessa Biomedical Research Center, Qatar University, Doha, Qatar

Hadeel T. Zedana Biomedical Research Center, Qatar University, Doha, Qatar;b Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar

Rand A. Alattarc Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar

Hatem Abusriwild Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar

Mahmoud Khatib A. A. Al-Ruweidia Biomedical Research Center, Qatar University, Doha, Qatar

Shamma Almuraikhya Biomedical Research Center, Qatar University, Doha, Qatar

Jabeed Parengalc Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Bassem Alharirid Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar

Hadi M. Yassinea Biomedical Research Center, Qatar University, Doha, Qatar

Ali A. Hssainf Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar

Arun Nairc Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Musaed Al Samawic Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Alaaeldin Abdelmajidc Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Jassim Al Suwaidig Department of Cardiology, Hamad Medical Corporation, Doha, Qatar

Mohamed Omar Saadh Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar

Muna Al-Maslamanic Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Ali S. Omranic Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar;e Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

https://orcid.org/0000-0001-5309-6358

Huseyin C. Yalcina Biomedical Research Center, Qatar University, Doha, QatarCorrespondence[email protected]

show all

Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date